Biden announces international COVID-19 vaccine sharing plan 06/03/2021 Health News, Fox News Flash top headlines for June 3 Fox News Flash top headlines are here....
South Australia announces six-day ‘circuit-breaker’ lockdown 11/18/2020 Health News, South Australia announced a six-day "circuit-breaker" lockdown for its nearly two million people Wednesday to...
Moderna Announces Supply Agreement with the Ministry of Public Health to Supply Qatar with mRNA Vaccine Against COVID-19 (mRNA-1273) 10/27/2020 Medications, CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 26, 2020-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA)...
ASPCA Announces Major Commitment to Help Vulnerable Animals and Low-Income Pet Owners 06/18/2019 Pet Care, blog_nyc-initiative_061819_main.jpg The ASPCA recently announced a groundbreaking, multi-year initiative to significantly improve the quality of...
Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder 03/20/2019 Medications, IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Mar. 19, 2019-- Urovant Sciences (Nasdaq: UROV),a clinical-stage biopharmaceutical company...
Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis 03/20/2019 Medications, DUBLIN, March 12, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the...
Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program for Ruxolitinib Cream in Atopic Dermatitis 12/28/2018 Medications, WILMINGTON, Del.--(BUSINESS WIRE)--Dec. 20, 2018-- Incyte (Nasdaq:INCY) today announced that the first patient has been...
Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis 12/04/2018 Medications, CAMBRIDGE, Mass., Dec. 2, 2018 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in...
Isofol Announces Initiation of a Pivotal Phase 3 Clinical Trial of arfolitixorin for the Treatment of Metastatic Colorectal Cancer 11/19/2018 Medications, GOTHENBURG, Sweden, November 15, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL)...
Trump Administration Announces Plan to Cut Drug Prices 10/27/2018 Health News, FRIDAY, Oct. 26, 2018 -- In an effort to cut high drug costs, the prices...